Australia markets open in 6 hours 51 minutes

Addex Therapeutics Ltd (ADDXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
1.5600-0.0900 (-5.45%)
As of 9:55AM EDT. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 550.58M
Enterprise value 331.46M
Trailing P/E N/A
Forward P/E 1-3.39
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)13.14
Price/book (mrq)2.57
Enterprise value/revenue 38.17
Enterprise value/EBITDA 7-2.81

Trading information

Stock price history

Beta (5Y monthly) 1.42
52-week change 30.00%
S&P500 52-week change 336.19%
52-week high 31.6500
52-week low 31.5600
50-day moving average 31.6500
200-day moving average 31.6500

Share statistics

Avg vol (3-month) 395
Avg vol (10-day) 3N/A
Shares outstanding 526.37M
Implied shares outstanding 6N/A
Float 20.08M
% held by insiders 17.00%
% held by institutions 131.59%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CHF.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Mar 2021

Profitability

Profit margin -290.78%
Operating margin (ttm)-288.86%

Management effectiveness

Return on assets (ttm)-24.93%
Return on equity (ttm)-52.69%

Income statement

Revenue (ttm)3.85M
Revenue per share (ttm)0.14
Quarterly revenue growth (yoy)-3.20%
Gross profit (ttm)-6.47M
EBITDA -11.19M
Net income avi to common (ttm)-11.19M
Diluted EPS (ttm)-0.4280
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)25.23M
Total cash per share (mrq)0.74
Total debt (mrq)489.8k
Total debt/equity (mrq)2.37
Current ratio (mrq)5.70
Book value per share (mrq)0.61

Cash flow statement

Operating cash flow (ttm)-10.79M
Levered free cash flow (ttm)-6.2M